Serum macrophage migration inhibitory factor concentration as a prostate cancer prognostic marker

被引:0
|
作者
Meyer-Siegler, KL
Tannenbaum, M
机构
来源
JOURNAL OF UROLOGY | 2002年 / 167卷 / 04期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:287 / 288
页数:2
相关论文
共 50 条
  • [41] Macrophage migration inhibitory factor
    Leng, L
    Bucala, R
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (12) : S475 - S477
  • [42] Macrophage migration inhibitory factor
    Lolis, E
    Bucala, R
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2003, 7 (02) : 153 - 164
  • [43] Macrophage migration inhibitory factor
    Baugh, JA
    Bucala, R
    [J]. CRITICAL CARE MEDICINE, 2002, 30 (01) : S27 - S35
  • [44] Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with susceptibility and severity of prostate cancer
    Meyer-Siegler, Katherine L.
    Vera, Pedro L.
    Iczkowski, Kenneth A.
    Bifulco, Carlo
    Lee, Annette
    Gregersen, Peter K.
    Leng, Lin
    Bucala, Richard
    [J]. JOURNAL OF UROLOGY, 2007, 177 (04): : 537 - 538
  • [45] Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence
    K L Meyer-Siegler
    P L Vera
    K A Iczkowski
    C Bifulco
    A Lee
    P K Gregersen
    L Leng
    R Bucala
    [J]. Genes & Immunity, 2007, 8 : 646 - 652
  • [46] Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence
    Meyer-Siegler, K. L.
    Vera, P. L.
    Iczkowski, K. A.
    Bifulco, C.
    Lee, A.
    Gregersen, P. K.
    Leng, L.
    Bucala, R.
    [J]. GENES AND IMMUNITY, 2007, 8 (08) : 646 - 652
  • [47] Macrophage migration inhibitory factor in the human prostate: Identification and immunocytochemical localization
    Arcuri, F
    del Vecchio, MT
    de Santi, MM
    Lalinga, AV
    Pallini, V
    Bini, L
    Bartolommei, S
    Parigi, S
    Cintorino, M
    [J]. PROSTATE, 1999, 39 (03): : 159 - 165
  • [48] Plasma Macrophage Migration Inhibitory Factor Concentration at Each Spectrum of Tuberculosis
    Najdah-Hidayah, Najdah
    Irawaty-Djaharuddin, Irawaty
    Ahyar-Ahmad, Ahyar
    Sabar-Pambudi, Sabar
    Handayani-Halik, Handayani
    Subair-Subair, Subair
    Andi-Tenriola, Andi
    Agus-Mumang, Andi
    Nurjannah-Lihawa, Nurjannah
    Nasrum-Massi, Muhammad
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2023, 43 (02): : 98 - 103
  • [49] Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.
    Ciftci, Rumeysa
    Tas, Faruk
    Aksit, Ece
    Vatansever, Sezai
    Karabulut, Senem
    Sen, Fatma
    Yildiz, Ibrahim
    Keskin, Serkan
    Bozbey, Hamza Ugur
    Kilic, Leyla
    Yasasever, Ceren Tilgen
    Tastekin, Didem
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [50] Serum levels of macrophage migration-inhibitory factor (MIF) have diagnostic, predictive and prognostic roles in epithelial ovarian cancer patients
    Tas, Faruk
    Karabulut, Senem
    Serilmez, Murat
    Ciftci, Rumeysa
    Duranyildiz, Derya
    [J]. TUMOR BIOLOGY, 2014, 35 (04) : 3327 - 3331